CN Patent

CN119112905A — 含雌孕激素的药物组合物、药物制剂及其制备方法、应用

Assigned to Wuhan Jiulong Humanwell Pharmaceutical Co ltd · Expires 2024-12-13 · 1y expired

What this patent protects

本发明公开了一种含雌孕激素的药物组合物、药物制剂及其制备方法、应用。该药物组合物包含以下质量分数的各组分：雌四醇0.01wt％‑0.2wt％、孕酮20wt％‑30wt％、中链脂肪酸甘油酯20wt％‑30wt％和溶剂45wt％‑55wt％；wt％为各组分的质量占所述药物组合物总质量的质量百分比。该药物组合物和药物制剂药代性质好，生物利用度高。

USPTO Abstract

本发明公开了一种含雌孕激素的药物组合物、药物制剂及其制备方法、应用。该药物组合物包含以下质量分数的各组分：雌四醇0.01wt％‑0.2wt％、孕酮20wt％‑30wt％、中链脂肪酸甘油酯20wt％‑30wt％和溶剂45wt％‑55wt％；wt％为各组分的质量占所述药物组合物总质量的质量百分比。该药物组合物和药物制剂药代性质好，生物利用度高。

Drugs covered by this patent

Patent Metadata

Patent number
CN119112905A
Jurisdiction
CN
Classification
—
Expires
2024-12-13
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Jiulong Humanwell Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.